AstraZeneca to Make Experimental Virus Vaccine Developed by Oxford University
May 8, 2020
1,928
10
0.52%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg News Episodes Around May 8, 2020
See what was published immediately before and after this episode.
2:03Now PlayingAstraZeneca to Make Experimental Virus Vaccine Developed by Oxford University
YouTube Description
as posted by the channelAstraZeneca has agreed to make an experimental inoculation developed by researchers at Oxford. Already being studied in humans, it could reach late-stage trials by the middle of the year.
From the U.S. to China to Germany, scientists are working around the clock to find a vaccine against the novel coronavirus. While experts caution that the process will take time—and that it’s not even a sure bet one can be found—some researchers say a vaccine could be ready for emergency use by the end of the year.
Most of the programs are in their early stages, meaning the gold standard of data, clinical trials with “blinded” placebo and therapeutic groups, is still a ways off. In normal times, the process to approve a drug or vaccine is slow and painstaking. It can be accelerated but at the risk of incurring unforeseen harm. When rules are loosened in the desire to get a vaccine to market quickly, it’s important to cast a skeptical eye on too-good-to-be-true data. It’s also possible that more than one usable vaccine could emerge. In the polio epidemic of the 1950s, scientists developed two different kinds, first an injection and later oral drops, to help eradicate the disease.
Subscribe to our YouTube channel
QUICKTAKE ON SOCIAL:
Follow QuickTake on Twitter: twitter.com/quicktake
Like QuickTake on Facebook: facebook.com/quicktake
Follow QuickTake on Instagram: instagram.com/quicktake
Subscribe to our newsletter
Email us at quicktakenews@gmail.com
QuickTake by Bloomberg is a global news network delivering up-to-the-minute analysis on the biggest news, trends and ideas for a new generation of leaders.
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.